Published in Int Angiol on February 23, 1989
Update on the clinical use of the low-molecular-weight heparin, parnaparin. Vasc Health Risk Manag (2009) 0.76
Risk factors for coronary artery disease in healthy persons with hyperinsulinemia and normal glucose tolerance. N Engl J Med (1989) 2.63
Enoxaparin plus compression stockings compared with compression stockings alone in the prevention of venous thromboembolism after elective neurosurgery. N Engl J Med (1998) 2.03
Hematologic improvement and response in elderly AML/RAEB patients treated with valproic acid and low-dose Ara-C. Leuk Res (2011) 1.50
Tungsten oxide nanowires grown on amorphous-like tungsten films. Nanotechnology (2015) 1.38
Aminotransferase and gamma-glutamyltranspeptidase levels in obesity are associated with insulin resistance and the metabolic syndrome. J Endocrinol Invest (2005) 1.27
Clinical implications of the reduced activity of the GH-IGF-I axis in older men. J Endocrinol Invest (2005) 1.17
A new 2D-based method for myocardial velocity strain and strain rate quantification in a normal adult and paediatric population: assessment of reference values. Cardiovasc Ultrasound (2009) 1.15
Understanding inhibitor development in haemophilia A: towards clinical prediction and prevention strategies. Haemophilia (2010) 1.12
Awareness of teratogenic effect of oral anticoagulants in fertile women. Thromb Haemost (2002) 1.07
Hyperinsulinemia in a normal population as a predictor of non-insulin-dependent diabetes mellitus, hypertension, and coronary heart disease: the Barilla factory revisited. Metabolism (1999) 1.04
Changes in insulin and lipid metabolism in males with asymptomatic hyperuricaemia. J Intern Med (1993) 1.04
Evidence that multiple risk factors for coronary artery disease exist in persons with abnormal glucose tolerance. Am J Med (1987) 1.03
Renal metabolism of C-peptide in man. J Clin Endocrinol Metab (1987) 1.00
Health status and quality of life of elderly persons with severe hemophilia born before the advent of modern replacement therapy. J Thromb Haemost (2009) 0.93
The insulin-like growth factor axis and plasma lipid levels in the elderly. J Clin Endocrinol Metab (1998) 0.93
Relationship between blood pressure and plasma insulin in non-obese and obese non-diabetic subjects. Diabetologia (1987) 0.92
Dental procedures in adult patients with hereditary bleeding disorders: 10 years experience in three Italian Hemophilia Centers. Haemophilia (2005) 0.92
Risk of acute cerebrovascular events related to low oestrogen oral contraceptive treatment. Ital J Neurol Sci (1998) 0.91
Models for institutional and professional accreditation of haemophilia centres in Italy. Haemophilia (2013) 0.91
Awaiting evidence-based recommendations on prophylaxis in adult patients. Haemophilia (2010) 0.90
Low-molecular-weight heparin for the long-term treatment of symptomatic venous thromboembolism: meta-analysis of the randomized comparisons with oral anticoagulants. J Thromb Haemost (2003) 0.90
Low molecular weight heparin versus warfarin in the prevention of recurrences after deep vein thrombosis. Thromb Haemost (1994) 0.90
The hormonal pathway to cognitive impairment in older men. J Nutr Health Aging (2012) 0.90
In vivo and in vitro resistance to maximal insulin-stimulated glucose disposal in insulin deficiency. Am J Physiol (1985) 0.89
Patterning-induced strain relief in single lithographic SiGe nanostructures studied by nanobeam x-ray diffraction. Nanotechnology (2012) 0.89
A retrospective study to describe the incidence of moderate to severe allergic reactions to factor IX in subjects with haemophilia B. Haemophilia (2011) 0.89
Prevalence of hyperinsulinaemia in patients with high blood pressure. J Intern Med (1992) 0.88
The treatment of elderly patients with aggressive non-Hodgkin's lymphomas: feasibility and efficacy of an intensive multidrug regimen. Leuk Lymphoma (1996) 0.88
Cardiopulmonary bypass: a low T4 and T3 syndrome with blunted thyrotropin (TSH) response to thyrotropin-releasing hormone (TRH). Horm Res (1986) 0.86
Serum levels of tumour necrosis factor-alpha in patients with B-cell chronic lymphocytic leukaemia. Eur J Cancer (1994) 0.86
Risk of venous thromboembolism and stroke associated with oral contraceptives. Role of congenital thrombophilias. Recenti Prog Med (1996) 0.86
Peripheral hyperinsulinemia of simple obesity: pancreatic hypersecretion or impaired insulin metabolism? J Clin Endocrinol Metab (1984) 0.85
Low molecular weight heparin (Alfa LHWH) compared with unfractionated heparin in prevention of deep-vein thrombosis after hip fractures. Int Angiol (1990) 0.84
Unraveling orbital ordering in La0.5Sr1.5MnO4. Phys Rev Lett (2004) 0.84
Source and purity of factor VIII products as risk factors for inhibitor development in patients with hemophilia A. J Thromb Haemost (2012) 0.84
Ordered Arrays of SiGe Islands from Low-Energy PECVD. Nanoscale Res Lett (2010) 0.84
P-VEBEC: a new 8-weekly schedule with or without rG-CSF for elderly patients with aggressive non-Hodgkin's lymphoma (NHL). Ann Oncol (1994) 0.83
Intracranial haemorrhage in the Italian population of haemophilia patients with and without inhibitors. Haemophilia (2011) 0.83
Predictors of postabsorptive ghrelin secretion after intake of different macronutrients. J Clin Endocrinol Metab (2006) 0.83
Low energy electronic excitations in the layered cuprates studied by copper L3 resonant inelastic x-ray scattering. Phys Rev Lett (2004) 0.83
The natural history of chronic hepatitis C in a cohort of HIV-negative Italian patients with hereditary bleeding disorders. Blood (2001) 0.83
A web-based clinical record 'xl'Emofilia' for outpatients with haemophilia and allied disorders in the Region of Emilia-Romagna: features and pilot use. Haemophilia (2008) 0.83
Hyperinsulinaemia, obesity, and syndrome X. J Intern Med (1994) 0.83
A comparative study on the quality of oral anticoagulant therapy (warfarin versus acenocoumarol). Thromb Haemost (1994) 0.83
Measuring, modelling and testing ozone exposure, flux and effects on vegetation in southern European conditions--what does not work? A review from Italy. Environ Pollut (2006) 0.83
Dextran/aspirin versus heparin/dihydroergotamine in preventing thrombosis after hip fractures. J Bone Joint Surg Br (1985) 0.82
Normal prostacyclin-like activity in thrombotic thrombocytopenic purpura. Thromb Haemost (1981) 0.82
Evidence for an independent relationship between plasma insulin and concentration of high density lipoprotein cholesterol and triglyceride. Atherosclerosis (1985) 0.82
Forum on: the role of recombinant factor VIII in children with severe haemophilia A. Haemophilia (2009) 0.81
Low-oestrogen oral contraceptives as a major risk factor for cerebral venous and sinus thrombosis: evidence from a clinical series. Ital J Neurol Sci (1999) 0.81
Central nervous system bleeding in patients with rare bleeding disorders. Haemophilia (2011) 0.81
Lack of association between UCP2 gene polymorphisms and obesity phenotype in Italian Caucasians. J Endocrinol Invest (2003) 0.81
Suppression of free fatty acids and triglycerides in normal and hypertriglyceridemic rats by the adenosine receptor agonist phenylisopropyladenosine. J Pharmacol Exp Ther (1986) 0.80
Acenocoumarol and pentoxifylline in intermittent claudication. A controlled clinical study. The APIC Study Group. Angiology (1989) 0.80
Loco-regional thrombolysis in the treatment of cerebral venous and sinus thrombosis: report of two cases. Acta Neurol Scand (2001) 0.80
Gastric tube oesophagoplasty for oesophageal atresia: a follow-up study. Part II: Radiologic, endoscopic and histologic controls. Z Kinderchir (1985) 0.79
Monitoring the kinetic evolution of self-assembled SiGe islands grown by Ge surface thermal diffusion from a local source. Nanotechnology (2014) 0.79
Desensitization of adenosine receptor-mediated inhibition of lipolysis. The mechanism involves the development of enhanced cyclic adenosine monophosphate accumulation in tolerant adipocytes. J Clin Invest (1986) 0.79
Nonspecific growth hormone responses to thyrotropin-releasing hormone in insulin-dependent diabetes: sex- and age-related pituitary responsiveness. J Clin Endocrinol Metab (1982) 0.79
Comparison of dual-energy X-ray absorptiometry, air displacement plethysmography and bioelectrical impedance analysis for the assessment of body composition in morbidly obese women. Eur J Clin Nutr (2013) 0.79
Disparate effects of prazosin and propranolol on lipid metabolism in a rat model. Metabolism (1983) 0.79
Anti-platelet effects of long-term treatment with gliclazide in diabetic patients. Thromb Res (1979) 0.79
Age-related changes in rat muscle glycogen synthase activity. J Gerontol (1987) 0.79
Influence of the menstrual cycle on glucose tolerance and insulin secretion. Am J Obstet Gynecol (1987) 0.79
Isochromosome 15q of maternal origin in a Prader-Willi patient with pituitary adenoma. Acta Genet Med Gemellol (Roma) (1996) 0.79
Effect of age and environmental factors on glucose tolerance and insulin secretion in a worker population. J Am Geriatr Soc (1986) 0.78
In vitro and in vivo effects of adrenaline and phentolamine on platelet function. Thromb Haemost (1978) 0.78
Fracture toughness of aged dental composites in combined mode I and mode II loading. J Biomed Mater Res (2000) 0.78
Invasive procedures and minor surgery in factor VII deficiency. Haemophilia (2012) 0.78
Duplex ultrasound diagnosis of symptomatic proximal deep vein thrombosis of lower limbs. Eur J Radiol (1992) 0.78
Insulin and C-peptide responses to 75 g oral glucose load in the healthy man. Diabete Metab (1986) 0.78
Congenital antithrombin III deficiency. Incidence and clinical features. Am J Med (1989) 0.77
Pituitary function in chronic heart failure in the elderly. J Endocrinol Invest (2002) 0.77
Systemic administration of antibiotics in the management of venous ulcers. A randomized clinical trial. J Am Acad Dermatol (1986) 0.77
Enhanced prolactin responsiveness to galanin in patients with Cushing's disease. Clin Endocrinol (Oxf) (1993) 0.77
Assessment of mitral regurgitation severity by Doppler color flow mapping of the vena contracta in dogs. J Vet Intern Med (2014) 0.77
Effect of exercise training and sucrose feeding on insulin-stimulated glucose uptake in rats with streptozotocin-induced insulin-deficient diabetes. Diabetes (1983) 0.77
Efficacy and safety during formulation switch of a pasteurized VWF/FVIII concentrate: results from an Italian prospective observational study in patients with von Willebrand disease. Haemophilia (2012) 0.77
Thromboembolic manifestations and congenital factor V deficiency: a family study. Haemostasis (1989) 0.77
A prospective registry of European haemophilia B patients receiving nonacog alfa, recombinant human factor IX, for usual use. Haemophilia (2011) 0.76
[Instrumental diagnosis of deep venous thrombosis. Reliability of phleboscintigraphy and the Doppler method as compared with phlebography]. Minerva Cardioangiol (1981) 0.76
Spectrum of F8 gene mutations in haemophilia A patients from a region of Italy: identification of 23 new mutations. Haemophilia (2010) 0.76
Accuracy of strain-gauge plethysmography as a diagnostic test in clinically suspected deep venous thrombosis. Thromb Res (1984) 0.76
Mechanism of hypertriglyceridemia in Dahl rats. Hypertension (1993) 0.76
Subcutaneous vs intravenous heparin in the treatment of deep venous thrombosis--a randomized clinical trial. Thromb Haemost (1990) 0.76
Searching for the role of primary prophylaxis in preventing inhibitor development in hemophilia A. J Thromb Haemost (2012) 0.76
[Study of platelet function in patients with migraine]. Haematologica (1984) 0.75
Characterization of a novel mutation in the F8 promoter region associated with mild hemophilia A and resistance to DDAVP therapy. J Thromb Haemost (2009) 0.75
Hemophilia severity score system: validation from an Italian Regional Hemophilia Reference Center. J Thromb Haemost (2009) 0.75
[Possibilities of telecobalt therapy of the spine with curative doses]. Strahlentherapie (1965) 0.75
Association between haemophilia and inherited thrombophilia: a single centre survey. Haemophilia (2011) 0.75
Management of coronary artery disease in a severe haemophilia patient with high titre inhibitor and anaphylaxis. Haemophilia (2009) 0.75
[Haemocoagulative modifications correlated with pregnancy]. Minerva Ginecol (2006) 0.75
Femtosecond dynamics in ferromagnetic metals investigated with soft x-ray resonant emission. Phys Rev Lett (2005) 0.75
[Hypercoagulability during pregnancy: evidences for a thrombophilic state]. Minerva Ginecol (2006) 0.75
LRP1/CD91 is up-regulated in monocytes from patients with haemophilia A: a single-centre analysis. Haemophilia (2013) 0.75
The use of central venous catheters in haemophilia patients. Haemophilia (2010) 0.75